Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/90901
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Statin use and pain in older people with cancer: a cross-sectional study
Author: Turner, J.
Shakib, S.
Singhal, N.
Hogan-Doran, J.
Prowse, R.
Johns, S.
Thynne, T.
Bell, J.
Citation: Journal of the American Geriatrics Society, 2014; 62(10):1900-1905
Publisher: Wiley
Issue Date: 2014
ISSN: 0002-8614
1532-5415
Statement of
Responsibility: 
Justin P. Turner, Sepehr Shakib, Nimit Singhal, Jonathon Hogan-Doran, Robert Prowse, Sally Johns, Tilenka Thynne and J. Simon Bel
Abstract: OBJECTIVES: To investigate statin use and pain in people with cancer aged 70 to 79 and 80 and older. DESIGN: Cross-sectional. SETTING: Medical oncology outpatient clinic at the Royal Adelaide Hospital. PARTICIPANTS: Individuals aged 70 and older who presented consecutively between January 2009 and June 2010 (n = 385), of whom 106 were aged 80 and older. MEASUREMENTS: Participants completed a structured data collection instrument, documenting medication use, comorbidities and a general pain assessment (10-point visual analogue scale (VAS)). Unadjusted and adjusted logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs) for factors associated with statin use. RESULTS: The prevalence of statin use was 35% (n = 97) in people aged 70 to 79 and 39% (n = 41) in those aged 80 and older. After adjusting for age, sex, Charlson Comorbidity Index, and analgesic use, statin use was associated with self-reported pain (VAS ≥ 5) (OR = 4.09, 95% CI = 1.32-12.68) in people aged 80 and older but not in those aged 70 to 79. Half of participants using statins (51% n = 70) had a palliative treatment approach. Of the 41 statin users aged 80 and older, 20 (49%) were using statins for primary prevention. CONCLUSION: The prevalence of statin use was similar in people aged 70 to 79 years and those aged 80 and older, with statin use associated with self-reported pain in people aged 80 and older. This highlights a potential benefit of "deprescribing" statins in older people with cancer, especially those aged 80 and older.
Keywords: aged; aged 80 and older; geriatric oncology; statins; HMG-CoA; deprescribe
Rights: © 2014, Copyright the Authors Journal compilation © 2014, The American Geriatrics Society
RMID: 0030023335
DOI: 10.1111/jgs.13051
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.